BusinessRespireRx Pharmaceuticals Inc. to Present at 10th Annual Biotech Showcase™ 2018By Nasdaq OMXJan 8, 2018, 1:45 PM UTC
BusinessAXIM Biotech Announces Successful Completion of Pre-IND Meeting with FDA on Comparable Product to Marinol; Green Light from FDA for IND SubmissionBy Nasdaq OMXDec 12, 2017, 2:01 PM UTC
BusinessAXIM Biotech Enters Term Sheet Agreement With US API Company to Develop Bioequivalent Product to MarinolBy Nasdaq OMXMar 28, 2017, 1:01 PM UTC
